# PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate

> **NCT01327495** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Washington** · enrollment: 62 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** placebo acyline
- **OTHER:** placebo gel
- **DRUG:** Testosterone 1% gel 1.25 g
- **DRUG:** Testosterone 1% gel 2.5 g
- **DRUG:** Testosterone 1% gel 5.0 g
- **DRUG:** testosterone 1% gel 10 g
- **DRUG:** testosterone 1% gel 15 g
- **DRUG:** Acyline

## Key facts

- **NCT ID:** NCT01327495
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327495, "PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01327495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*